Sequent Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Sell
1,636
-152
-9% -$35.4K 0.09% 166
2026
Q1
$437K Buy
1,788
+57
+3% +$13.3K 0.11% 142
2025
Q4
$358K Buy
1,731
+115
+7% +$22.7K 0.09% 154
2025
Q3
$300K Buy
1,616
+27
+2% +$4.63K 0.09% 165
2025
Q2
$243K Sell
1,589
-94
-6% -$14.4K 0.08% 139
2025
Q1
$279K Buy
+1,683
New +$263K 0.1% 123
2024
Q4
Sell
-1,295
Closed -$210K 150
2024
Q3
$210K Buy
+1,295
New +$206K 0.07% 142

Other funds holding JNJ

Sequent Planning's JNJ Position: Q2 2026 in Review

Sequent Planning reduced its Johnson & Johnson (JNJ) stake by 8.5% in Q2 2026, selling an estimated $35.4K and leaving 1,636 shares worth $415K. The position accounts for 0.09% of the portfolio, ranked #166.

Sequent Planning first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. The position peaked at $437K in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sequent Planning held 1,636 shares of Johnson & Johnson worth $415K as of Q2 2026.
  • Sequent Planning sold 152 Johnson & Johnson shares in Q2 2026, an estimated $35.4K.
  • Johnson & Johnson made up 0.09% of Sequent Planning's portfolio in Q2 2026, its #166 holding.
  • Sequent Planning first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • Sequent Planning's Johnson & Johnson position peaked at $437K in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sequent Planning's 13F filing for Q2 2026, filed 14 Aug 2026.